Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 27, 2017
The Use of Microdosing in the Development of Small Organic and Protein TherapeuticsMats BergstromOxford Open Immunology|June 30, 2025
PET in the characterization of immune diseases and development of therapeuticsNatasha Patel, Mats Bergstrom, Philip S Murphy, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 17, 2008
Modeling spheroid growth, PET tracer uptake, and treatment effects of the Hsp90 inhibitor NVP-AUY922Mats Bergstrom, Azita Monazzam, Pasha Razifar, et al.Alternatives to Laboratory Animals : ATLA|January 19, 2019
Phase 0, including microdosing approaches: Applying the Three Rs and increasing the efficiency of human drug developmentTal Burt, Le Thuy Vuong, Elizabeth Baker, et al.Drug Discovery Today|October 4, 2016
Molecular imaging in oncology drug developmentSarah R Mudd, Robert A Comley, Mats Bergstrom, et al.Mabs|February 5, 2014
Preclinical evaluation of 89Zr-labeled anti-CD44 monoclonal antibody RG7356 in mice and cynomolgus monkeys: Prelude to Phase 1 clinical studiesDanielle J Vugts, Derrek A Heuveling, Marijke Stigter-van Walsum, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|April 29, 2010
Two binding sites for [3H]PBR28 in human brain: implications for TSPO PET imaging of neuroinflammationDavid R Owen, Owain W Howell, Sac-Pham Tang, et al.EJNMMI Research|December 21, 2019
Quantifying disease activity in rheumatoid arthritis with the TSPO PET ligand <sup>18</sup>F-GE-180 and comparison with <sup>18</sup>F-FDG and DCE-MRIMarius de Groot, Neel Patel, Roido Manavaki, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|September 9, 2022
Multimodal imaging distribution assessment of a liposomal antibiotic in an infectious disease modelShih-Hsun Cheng, M Reid Groseclose, Cindy Mininger, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 9, 2019
Immuno-PET Imaging to Assess Target Engagement: Experience from <sup>89</sup>Zr-Anti-HER3 mAb (GSK2849330) in Patients with Solid TumorsC Willemien Menke-van der Houven van Oordt, Adam McGeoch, Mats Bergstrom, et al.Pageof 2